7.37[J] Molecular and Engineering Aspects of Biotechnology


Class Info

Covers biological and bioengineering principles underlying the development and therapeutic use of recombinant proteins and stem cells; glycoengineering of recombinant proteins; normal and pathological signaling by growth factors and their receptors; receptor trafficking; monoclonal antibodies as therapeutics; protein pharmacology and delivery; stem cell-derived tissues as therapeutics; RNA therapeutics; combinatorial protein engineering; and new antitumor drugs.

This class has 2.005, 3.012, 5.60, 20.110, and 7.06 as prerequisites.

7.37[J] will not be offered this semester. It will be available in the Spring semester, and will be instructed by H. Lodish and L. Griffith.

This class counts for a total of 12 credits.

You can find more information at the MIT + 7.37 - Google Search site.

MIT 7.37[J] Molecular and Engineering Aspects of Biotechnology Related Textbooks
MIT 7.37[J] Molecular and Engineering Aspects of Biotechnology On The Web

© Copyright 2015